PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MD Anderson Research Highlights for August 7, 2024

Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and ALL, and liquid biopsies for early pancreatic cancer detection

2024-08-07
(Press-News.org) HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Recent developments at MD Anderson include insights into evolutionary cellular adaptations to environmental stressors, potential targets to overcome trouble swallowing in head and neck cancer patients treated with radiation therapy, a promising chemotherapy-free combination treatment for patients with a subset of acute lymphocytic leukemia, a single-cell atlas for stomach cancer metastasis, encouraging results of a PARP inhibitor on patients with advanced cancers and specific DNA damage repair mutations, and a liquid biopsy signature that could improve early pancreatic cancer detection.

Rapid adaptation to environmental change in yeast is driven by hidden genetic variation
Heat shock protein 90 (Hsp90) is an essential protein folding machine within our cells, with crucial roles in environmental stress response and cell signaling. However, we do not fully understand how Hsp90 influences a population’s ability to adapt to environmental stressors. To provide insights into this critical area of evolutionary biology, researchers led by Georgios Karras, Ph.D., explored how domesticated yeast manage environmental stress on Hsp90 from ethanol, which is a product of the fermentation process in beer and bread making. They demonstrated that domesticated yeasts evolved with extra copies of genes that make the metabolism of relevant sugars like maltose more robust to ethanol stress, improving their ability to survive under industrial fermentation conditions. This study uncovers Hsp90 as a vulnerability to environmental exposure and shows how hidden Hsp90-dependent genetic variation has fueled adaptive evolution in a real-life setting. These results have potential implications for human health and biotechnology. Learn more in Science.  

Specific nerves are associated with poorer outcomes in oral cancer treated with radiation
Patients with human papillomavirus (HPV)-mediated head and neck cancers have a favorable prognosis, but radiation therapy can often lead to dysphagia, or trouble swallowing. Cancer cells are known to change nerve signals in the tumor microenvironment, but how these nerve changes affect swallowing is poorly understood. Therefore, researchers led by Moran Amit, M.D., Ph.D., Katherine Hutcheson, Ph.D., and Shajedul Islam, Ph.D., examined samples from patients with head and neck cancers treated with radiation to compare tumor-associated neuronal changes in correlation with patient outcomes. Tumors enriched with specific nerve types were linked to poorer swallowing outcomes, and follow-up in vivo testing of this mechanism confirmed these results. The preclinical study shows that certain neuronal signaling pathways directly affect swallowing function after treatment and may serve as biomarkers for patient risk assessment. The authors suggest future studies should investigate blocking these target signals by repurposing existing neurological drugs to potentially preserve swallowing function and improve patient outcomes. Learn more in Science Translational Medicine.

Chemotherapy-free combination therapy shows promise for Ph-positive ALL
Patients with newly diagnosed Philadelphia chromosome (Ph)-positive acute lymphocytic leukemia (ALL) have limited treatment options and end up needing intensive chemotherapy or stem cell transplants. To investigate alternative treatments, researchers led by Hagop Kantarjian, M.D., and Elias Jabbour, M.D., evaluated the chemotherapy-free combination therapy of blinatumomab and ponatinib in 60 patients with Ph-positive ALL. In updated results with a median follow-up of 24 months, the combination achieved a complete response rate of 83% and a negative measurable residual disease in 98% of patients. The estimated three-year overall survival rate and event-free survival rate were 91% and 77%, respectively. Only two patients required hematopoietic stem cell transplants, and side effects were manageable. The study highlights the potential of this chemotherapy-free combination therapy to reduce the need for stem cell transplants and improve outcomes for patients with Ph-positive ALL. Learn more in the Journal of Clinical Oncology.

Atlas of metastatic progression of stomach cancer suggests potential therapeutic target
Research on the metastatic progression of gastric adenocarcinoma (GAC), an aggressive type of stomach cancer with a poor patient prognosis, is limited. To provide further insights, researchers led by Pawel Mazur, Ph.D., Jaffer Ajani, M.D., and Linghua Wang, M.D., Ph.D., performed single-cell transcriptome and immune profiling of 68 paired treatment-naïve and primary metastatic tumors to observe changes in the tumor microenvironment (TME) during metastatic progression. The results showed that cancer cells in liver and peritoneal metastases avoid ferroptosis, or cell death, by upregulating a specific enzyme, GPX4. Inhibiting GPX4 reduced tumor growth and enhanced the efficacy of chimeric antigen receptor (CAR) T cell therapy. The study provides the largest single-cell atlas of metastatic GAC and suggests that cancer cells co-evolve with their TME at metastatic sites, highlighting the therapeutic potential of combining ferroptosis-targeting treatments with CAR T cell therapy to improve outcomes for patients with metastatic GAC. Learn more in Gastroenterology.

PARP inhibitor shows promise for advanced cancers with BRCA1/2 mutations
Talazoparib is a PARP inhibitor that blocks DNA damage repair (DDR), leading to cancer cell death. It is used for treating certain types of breast and ovarian cancers with BRCA1/2 mutations, but its effects on other cancers with BRCA1/2 mutations or other DDR deficiencies are unknown. In a Phase II study, researchers led by Sarina Piha-Paul, M.D., and Funda Meric-Bernstam, M.D., tested the efficacy of talazoparib in 79 patients with metastatic or inoperable advanced cancers with somatic or germline BRCA1/2 mutations as well as patients with PTEN tumor suppressor or other DDR pathway mutations. Talazoparib was effective for patients with somatic and germline BRCA1/2 mutations, with a clinical benefit rate of 32.5% and 30.6%, respectively. PTEN mutations were associated with limited clinical benefit, reduced survival and shorter time to progression with talazoparib, highlighting a need to further investigate whether PTEN can be a prognostic or predictive biomarker of treatment response. Learn more in NPJ Precision Oncology. 

Blood-based miRNA signature improves early-stage pancreatic cancer detection
Pancreatic cancer has poor survival outcomes in part due to late diagnosis in asymptomatic patients. The CA19-9 biomarker has limited sensitivity for early-stage cancer, leading researchers Subrata Sen, Ph.D., Warapen Treekitkarnmongkol, Ph.D., and Jianliang Dai, Ph.D., to investigate new early detection approaches. The researchers examined 2,083 plasma micro-RNAs (miRNAs) from 203 age-matched samples. Focusing on cancer-associated pathways, they developed a three-miRNA signature that improved early detection when combined with CA19-9 compared to CA19-9 alone. For stage I and II cases, the sensitivities of the combination were 92% and 40% in discriminating from healthy and pancreatitis controls, respectively, compared to 60% and 11% for CA19-9 alone. Validation studies revealed an increase in diagnostic performance of the signature with early detection of up to 12 months before diagnosis. This miRNA signature merits further investigation with larger cohorts in different pancreatic cancer subtypes. Learn more in Gastro Hep Advances.

In case you missed it
Read below to catch up on recent MD Anderson press releases.

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer MD Anderson and collaborators to launch project studying T cells on International Space Station MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab Read this press release in the MD Anderson Newsroom.

- 30 -

END



ELSE PRESS RELEASES FROM THIS DATE:

Some e-cigarette chemicals mimic nicotine, possibly bypassing regulation

2024-08-07
DURHAM, N.C. – In what appears to be an effort to bypass public health regulations covering vaping products, some tobacco companies have begun replacing nicotine in e-cigarettes with related chemicals that have similar properties but unknown health effects, Duke Health researchers report. In a research letter appearing Aug. 7 in JAMA, study authors at Duke and Yale University also found that the quantity of these chemicals, known as nicotine analogs, are not accurately disclosed on the packaging. “Vaping products containing nicotine are subject to federal laws that prohibit sales to people  under the age of 21,” said study co-author Sairam V. Jabba, ...

New 400-year temperature record shows Great Barrier Reef is facing catastrophic damage, researchers warn

New 400-year temperature record shows Great Barrier Reef is facing catastrophic damage, researchers warn
2024-08-07
The Great Barrier Reef is under critical pressure, with warming sea temperatures and mass coral bleaching events threatening to destroy the remarkable ecology, biodiversity, and beauty of the world’s largest coral reef, according to new research published today. ‘Highest ocean heat in four centuries places Great Barrier Reef in danger’, published in Nature (8 August), led by University of Wollongong (UOW) Honorary Fellow and University of Melbourne Lecturer Dr Benjamin Henley, provides new evidence of the impact that rising sea surface temperatures ...

Corn’s ‘missing link’

Corn’s ‘missing link’
2024-08-07
Cold Spring Harbor Laboratory (CSHL) has begun to unravel a mystery millennia in the making. Our story begins 9,000 years ago. It was then that maize was first domesticated in the Mexican lowlands. Some 5,000 years later, the crop crossed with a species from the Mexican highlands called teosinte mexicana. This resulted in cold adaptability. From here, corn spread across the continent, giving rise to the vegetable that is now such a big part of our diets. But how did it adapt so quickly? What biological mechanisms allowed the highland crop’s traits to take hold? Today, a potential answer emerges. CSHL Professor and HHMI Investigator Rob Martienssen had ...

Scientists uncover hidden forces causing continents to rise

Scientists uncover hidden forces causing continents to rise
2024-08-07
Scientists at the University of Southampton have answered one of the most puzzling questions in plate tectonics: how and why ‘stable’ parts of continents gradually rise to form some of the planet’s greatest topographic features. They have found that when tectonic plates break apart, powerful waves are triggered deep within the Earth that can cause continental surfaces to rise by over a kilometre. Their findings help resolve a long-standing mystery about the dynamic forces that shape and connect some of the Earth’s most ...

Variability in constituents of e-cigarette products containing nicotine analogues

2024-08-07
About The Study: Discrepancies were observed between labeled and measured concentrations of nicotine analogues in e-cigarettes and e-cigarette liquids marketed as nicotine replacements and exempt from FDA’s regulatory purview. Such discrepancies may lead to uncertainty about user exposure. When coupled with the largely unknown acute and chronic inhalation hazards and addictive potential of nicotine analogues, assessing product risk based on exposure becomes challenging from a clinical and regulatory standpoint. With e-cigarettes increasingly considered for smoking cessation, the advent of nicotine analogue–containing products with ...

A vaping cessation text message program for adolescent e-cigarette users

2024-08-07
About The Study: A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels. Quote from corresponding author Amanda L. Graham, PhD: “Health care providers, teachers, and parents have been asking how to help teens quit vaping. This study is a critical breakthrough that demonstrates the power of a behavioral intervention for vaping cessation. Text messages serve as powerful reminders of an initial commitment to quit and can deliver proven behavior change support right to a young person’s phone. “We also did not see evidence that teens who quit ...

Neighborhood socioeconomic disadvantage across the life course and premature mortality

2024-08-07
About The Study: Low neighborhood socioeconomic status was associated with premature mortality in this study. The risk of premature mortality was greatest among individuals experiencing persistently low neighborhood socioeconomic status from young to middle adulthood. Place-based interventions that target neighborhood social determinants of health should be designed from a life course perspective that accounts for early-life socioeconomic inequality.  Corresponding Author: To contact the corresponding author, Wayne R. Lawrence, DrPH, email wayne.lawrence@nih.gov. To access the embargoed ...

Cocaine discovery could pave way for treatment for substance abuse

2024-08-07
You have probably heard of dopamine. The substance also known as the “feel-good hormone”. Drugs such as cocaine cause a surge of dopamine in the brain. Normally, a protein in the brain called the dopamine transporter (DAT) helps regulate dopamine levels and prevent the brain from thinking that every experience is pleasurable. However, when affected by cocaine, the brain is unable to regulate dopamine levels. Previously, researchers did not know how cocaine affects the different transporters in the brain, but a new study from the University of Copenhagen has changed that. “We have learned how cocaine binds to the dopamine transporter, which is ...

Link discovered between sensory neurons and breast cancer metastasis

2024-08-07
Cancer doesn’t grow in a vacuum—each tumor grows in a particular microenvironment within the body and spreads through a tangled web of vasculature and nerves. Scientists have come to understand that the most potent therapies address cancer in context—accounting for both the tumor and the support structure that forms around it. Now, a new paper in Nature reveals that the activation of sensory nerves within breast tumors is playing a critical role in promoting not only cancer growth but also its spread, known as metastasis. The findings—that sensory neurons ...

Plants show surprising diversity in arid landscape

Plants show surprising diversity in arid landscape
2024-08-07
Understanding how plants cope with climatic extremes and grazing pressure is important for reliable prediction about future biodiversity and the functioning of dryland ecosystems[1]. An international team, coordinated by KAUST’s Fernando Maestre, has assessed how 20 chemical and morphological plant functional traits jointly respond to changes in aridity and grazing pressure across global drylands. Increasing aridity and grazing pressure could be expected to reduce the level of plant diversity. However, the diversity of plant traits — including key traits linked to nutrient cycling such as specific leaf area and foliar ...

LAST 30 PRESS RELEASES:

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

Anti-anxiety and hallucination-like effects of psychedelics mediated by distinct neural circuits

How do microbiomes influence the study of life?

Plant roots change their growth pattern during ‘puberty’

Study outlines key role of national and EU policy to control emissions from German hydrogen economy

Beloved Disney classics convey an idealized image of fatherhood

[Press-News.org] MD Anderson Research Highlights for August 7, 2024
Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and ALL, and liquid biopsies for early pancreatic cancer detection